Suppr超能文献

盐摄入对高血压发病机制及治疗的影响

Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.

作者信息

Rust Petra, Ekmekcioglu Cem

机构信息

Institute of Nutritional Sciences, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria.

Institute of Environmental Health, Centre for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria.

出版信息

Adv Exp Med Biol. 2017;956:61-84. doi: 10.1007/5584_2016_147.

Abstract

Excessive dietary salt (sodium chloride) intake is associated with an increased risk for hypertension, which in turn is especially a major risk factor for stroke and other cardiovascular pathologies, but also kidney diseases. Besides, high salt intake or preference for salty food is discussed to be positive associated with stomach cancer, and according to recent studies probably also obesity risk. On the other hand a reduction of dietary salt intake leads to a considerable reduction in blood pressure, especially in hypertensive patients but to a lesser extent also in normotensives as several meta-analyses of interventional studies have shown. Various mechanisms for salt-dependent hypertension have been put forward including volume expansion, modified renal functions and disorders in sodium balance, impaired reaction of the renin-angiotensin-aldosterone-system and the associated receptors, central stimulation of the activity of the sympathetic nervous system, and possibly also inflammatory processes.Not every person reacts to changes in dietary salt intake with alterations in blood pressure, dividing people in salt sensitive and insensitive groups. It is estimated that about 50-60 % of hypertensives are salt sensitive. In addition to genetic polymorphisms, salt sensitivity is increased in aging, in black people, and in persons with metabolic syndrome or obesity. However, although mechanisms of salt-dependent hypertensive effects are increasingly known, more research on measurement, storage and kinetics of sodium, on physiological properties, and genetic determinants of salt sensitivity are necessary to harden the basis for salt reduction recommendations.Currently estimated dietary intake of salt is about 9-12 g per day in most countries of the world. These amounts are significantly above the WHO recommended level of less than 5 g salt per day. According to recent research results a moderate reduction of daily salt intake from current intakes to 5-6 g can reduce morbidity rates. Potential risks of salt reduction, like suboptimal iodine supply, are limited and manageable. Concomitant to salt reduction, potassium intake by higher intake of fruits and vegetables should be optimised, since several studies have provided evidence that potassium rich diets or interventions with potassium can lower blood pressure, especially in hypertensives.In addition to dietary assessment the gold standard for measuring salt intake is the analysis of sodium excretion in the 24 h urine. Spot urine samples are appropriate alternatives for monitoring sodium intake. A weakness of dietary evaluations is that the salt content of many foods is not precisely known and information in nutrient databases are limited. A certain limitation of the urine assessment is that dietary sources contributing to salt intake cannot be identified.Salt reduction strategies include nutritional education, improving environmental conditions (by product reformulation and optimization of communal catering) up to mandatory nutrition labeling and regulated nutrition/health claims, as well as legislated changes in the form of taxation.Regarding dietary interventions for the reduction of blood pressure the Dietary Approaches to Stop Hypertension (DASH) diet can be recommended. In addition, body weight should be normalized in overweight and obese people (BMI less than 25 kg/m), salt intake should not exceed 5 g/day according to WHO recommendations (<2 g sodium/day), no more than 1.5 g sodium/d in blacks, middle- and older-aged persons, and individuals with hypertension, diabetes, or chronic kidney disease, intake of potassium (~4.7 g/day) should be increased and alcohol consumption limited. In addition, regular physical activity (endurance, dynamic resistance, and isometric resistance training) is very important.

摘要

过量摄入膳食盐(氯化钠)会增加患高血压的风险,而高血压又是中风和其他心血管疾病以及肾脏疾病的主要危险因素。此外,高盐摄入或对咸味食物的偏好被认为与胃癌呈正相关,并且根据最近的研究,可能还与肥胖风险有关。另一方面,减少膳食盐摄入量会使血压显著降低,尤其是高血压患者,但在正常血压者中也有一定程度的降低,多项干预性研究的荟萃分析已表明这一点。已经提出了多种与盐相关的高血压机制,包括血容量扩张、肾功能改变和钠平衡紊乱、肾素 - 血管紧张素 - 醛固酮系统及其相关受体的反应受损、交感神经系统活动的中枢刺激,以及可能的炎症过程。并非每个人对膳食盐摄入量的变化都会出现血压改变,据此可将人群分为盐敏感和盐不敏感组。据估计,约50 - 60%的高血压患者对盐敏感。除了基因多态性外,在老年人、黑人以及患有代谢综合征或肥胖症的人群中,盐敏感性会增加。然而,尽管与盐相关的高血压效应机制越来越为人所知,但仍需要对钠的测量、储存和动力学、生理特性以及盐敏感性的基因决定因素进行更多研究,以强化减盐建议的依据。目前估计,世界上大多数国家的膳食盐摄入量约为每天9 - 12克。这些摄入量明显高于世界卫生组织建议的每天少于5克盐的水平。根据最近的研究结果,将每日盐摄入量从当前水平适度降低至5 - 6克可降低发病率。减盐的潜在风险,如碘供应不足,是有限且可控的。在减盐的同时,应通过增加水果和蔬菜的摄入量来优化钾的摄入,因为多项研究已证明富含钾的饮食或钾干预措施可降低血压,尤其是在高血压患者中。除了膳食评估外,测量盐摄入量的金标准是分析24小时尿液中的钠排泄量。随机尿样是监测钠摄入量的合适替代方法。膳食评估的一个缺点是许多食物的盐含量并不确切知晓,营养数据库中的信息也有限。尿液评估的一个特定局限性是无法确定导致盐摄入的膳食来源。减盐策略包括营养教育、改善环境条件(通过产品重新配方和优化公共餐饮)直至强制营养标签和规范营养/健康声明,以及税收形式的立法变革。关于降低血压的膳食干预措施,可推荐采用终止高血压膳食疗法(DASH饮食)。此外,超重和肥胖者(体重指数小于25kg/m²)应使体重正常化,根据世界卫生组织的建议,盐摄入量不应超过5克/天(钠摄入量<2克/天),黑人、中老年人以及患有高血压、糖尿病或慢性肾病的个体钠摄入量不应超过1.5克/天,应增加钾的摄入量(约4.7克/天)并限制酒精消费。此外,定期进行体育活动(耐力、动态阻力和等长阻力训练)非常重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验